(Q41757804)

8 October 2017

1 reference

title

Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays (English)

1 reference

8 October 2017

0 references

Chapman JD

1

1 reference

8 October 2017

Engelhardt EL

2

1 reference

8 October 2017

Stobbe CC

3

1 reference

8 October 2017

Schneider RF

4

1 reference

8 October 2017

Hanks GE

5

1 reference

8 October 2017

1 March 1998

1 reference

Radiotherapy and Oncology

8 October 2017

1 reference

8 October 2017

46

1 reference

8 October 2017

3

1 reference

8 October 2017

229-237

1 reference

Radiopharmaceuticals for Imaging Hypoxia

8 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

7 January 2021

Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

7 January 2021

Quantitative measurements of oxygen tension in normal tissues and in the tumours of patients before and after radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

7 January 2021

Hypoxic Sensitizers — Implications for Radiation Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

7 January 2021

The detection and measurement of hypoxic cells in solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

7 January 2021

Measurement of tumor hypoxia by invasive and non-invasive procedures: a review of recent clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

7 January 2021

A marker for hypoxic cells in tumours with potential clinical applicability

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

7 January 2021

Keynote address: cellular reduction of nitroimidazole drugs: potential for selective chemotherapy and diagnosis of hypoxic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

7 January 2021

Phase I trial of the hypoxic cell radiosensitizer SR-2508: the results of the five to six week drug schedule

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

7 January 2021

Clinical experience with nitroimidazoles as radiosensitizers

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

1 reference

7 January 2021

The labelling of EMT-6 tumours in BALB/C mice with 14C-misonidazole

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

7 January 2021

The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

7 January 2021

Changes in misonidazole binding with hypoxic fraction in mouse tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

7 January 2021

Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

7 January 2021

Relationship between radiobiological hypoxia and direct estimates of tumour oxygenation in a mouse tumour model

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

7 January 2021

Comparing techniques of measuring tumor hypoxia in different murine tumors: Eppendorf pO2 Histograph, [3H]misonidazole binding and paired survival assay

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

7 January 2021

Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

7 January 2021

Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

7 January 2021

Tumor hypoxia: its impact on cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

7 January 2021

Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

7 January 2021

Nitroimidazoles and imaging hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

7 January 2021

Non-invasive assessment of human tumour hypoxia with 123I-iodoazomycin arabinoside: preliminary report of a clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

7 January 2021

Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

7 January 2021

Radiolabelled fluoromisonidazole as an imaging agent for tumor hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

7 January 2021

Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

7 January 2021

Radiation and High-Dose Metronidazole in Supratentorial Glioblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

7 January 2021

A novel technique for measuring human tissue pO2 at the cellular level

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

7 January 2021

Blood Flow and Tissue Oxygenation of Human Tumors: An Update

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

7 January 2021

Studies on the toxicity and radiosensitizing ability of misonidazole under conditions of prolonged incubation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900186-2

7 January 2021

10.1016/S0167-8140(97)00186-2

Identifiers

DOI

1 reference

8 October 2017

1 reference